Treatment of cutaneous abscess: a double-blind clinical study

Clicks: 486
ID: 112886
1985
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #7 of 23 articles by views in Annals of emergency medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Controversy exists about the value of antibiotic therapy following incision and drainage of cutaneous abscess. We undertook a randomized double-blind study to clarify the controversy. Adult patients with cutaneous abscesses who received outpatient surgical therapy were entered into the study. Follow …
Reference Key
jl1985annalstreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Llera JL, Levy RC
Are you one of these authors? Claim your profile
Journal Annals of emergency medicine
Year 1985
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/3880635
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent middle aged Clinical Trial Randomized Controlled Trial Double-Blind Method Random Allocation pmid:3880635 doi:10.1016/s0196-0644(85)80727-7 j l llera r c levy abscess / drug therapy* cephalosporins / therapeutic use* cephradine / therapeutic use* skin diseases / drug therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.